艾伯维高管称潜在交易不限于早期阶段,聚焦核心领域:免疫学、神经科学、肿瘤学及肥胖症布局

美股速递
Feb 04

艾伯维公司高管近日表示,公司在寻求潜在交易时不会局限于早期阶段项目,而是将战略重点集中于核心业务领域。这些关键领域包括免疫学、神经科学、肿瘤学,以及正在积极拓展的肥胖症治疗方向。公司旨在通过多元化的合作方式强化产品管线,推动长期增长。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10